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Abstract
The blood-brain barrier is a restrictive interface between the brain parenchyma and the
intravascular compartment. Tight junctions contribute to the integrity of the blood-brain barrier.
Hypoxic-ischemic damage to the blood-brain barrier could be an important component of fetal
brain injury. We hypothesized that increases in blood-brain barrier permeability after ischemia
depend upon the duration of reperfusion and that decreases in tight junction proteins are associated
with the ischemia-related impairment in blood-brain barrier function in the fetus. Blood-brain
barrier function was quantified with the blood-to-brain transfer constant (Ki) and tight junction
proteins by Western immunoblot in fetal sheep at 127 days-of-gestation without ischemia, and 4-,
24-, or 48-h after ischemia. The largest increase in Ki (P<0.05) was 4-h after ischemia. Occludin
and claudin-5 expressions decreased at 4-h, but returned toward control levels 24- and 48-h after
ischemia. Zonula occludens-1 and -2 decreased after ischemia. Inverse correlations between Ki
and tight junction proteins suggest that the decreases in tight junction proteins contribute to
impaired blood-brain barrier function after ischemia. We conclude that impaired blood-brain
barrier function is an important component of hypoxic-ischemic brain injury in the fetus, and that
increases in quantitatively measured barrier permeability (Ki) change as a function of the duration
of reperfusion after ischemia. The largest increase in permeability occurs 4-h after ischemia and
blood-brain barrier function improves early after injury because the blood-brain barrier is less
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permeable 24- and 48- than 4-h after ischemia. Changes in the tight junction molecular
composition are associated with increases in blood-brain barrier permeability after ischemia.
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blood-brain barrier; brain; fetus; ischemia-reperfusion; ovine; tight junction proteins
The blood-brain barrier is composed of a continuous layer of endothelial cells connected by
intercellular tight junctions (Betz and Goldstein, 1986) and serves as an interface between
circulating blood, brain interstitium and parenchyma, maintaining central nervous system
(CNS) homeostasis (Betz, 1992). Although the basement membrane, pericytes, and astrocyte
end-feet processes are also important components of the neurovascular unit contributing to
the integrity of the blood-brain barrier, the tight junctions of endothelial cells represent the
primary restrictive barrier of the blood-brain barrier (Hawkins and Davis, 2005). Tight
junctions are composed of transmembrane proteins, including claudins and occludin, which
are the primary structures responsible for blood-brain barrier properties. Proteins of the
claudin family form the primary seal between adjacent endothelial cells, whereas occludin
functions as a support molecule increasing electrical resistance across the barrier and
decreasing paracellular permeability (Hawkins and Davis, 2005). Zonula occludens (ZO)-1
and ZO-2, located at the cytoplasmic surface of endothelial cells, stabilize tight junctions by
connecting them to actin (Hawkins and Davis, 2005).
Hypoxic-ischemic brain injury is the most common neurologic problem in the perinatal
period (Vannucci, 1993) and could damage the integrity of the blood-brain barrier. We have
shown that blood-brain barrier development takes place throughout fetal-neonatal
development (Stonestreet et al., 1996). Although previous studies have shown that hypoxic-
ischemic insults can damage the immature blood-brain barrier, the majority of studies have
been carried out in rodent models (Fan et al., 2009, Leonardo and Pennypacker, 2009) and,
consequently, the effects of ischemia have not been quantitatively determined with the
blood-to-brain transfer constant in fetal subjects. Hence, information is not available
regarding the effects of hypoxia-ischemia on quantitative changes in blood-brain barrier
permeability, on the distribution of damage to different brain regions, or concerning
potential mechanisms underlying the changes in barrier permeability in the immature brain,
and particularly not in the brain of a precocial species such as sheep. Only two studies have
examined blood-brain barrier function in the fetus exposed to hypoxia-ishemia (Lou et al.,
1979, Tweed et al., 1981) and the results of these studies differ. Lou et. al found the blood-
brain barrier became leaky to the albumin-bound tracer Evans blue after prolonged umbilical
cord occlusion (Lou et al., 1979), whereas, Tweed, et. al found the blood-brain barrier was
relatively resistant to severe asphyxia (Tweed et al., 1981). Differences in the responses of
the blood-brain barrier to hypoxia-ischemia have also been observed in newborn pigs
(Temesvari and Kovacs, 1988, Mirro et al., 1991, Armstead et al., 1992, Stonestreet et al.,
1992). Global ischemia and bilateral pneumothoracies have been shown to result in impaired
blood-brain barrier function in newborn pigs (Temesvari and Kovacs, 1988, Mirro et al.,
1991) whereas, increases in blood-brain barrier permeability were not detected after severe
hypotensive-hypoxia/hypercarbia in newborn pigs (Stonestreet et al., 1992). The increases in
barrier permebility that were observed in the newborn pigs after inducing global ischemia by
increasing intracranial pressure above mean arterial blood pressure for 20 minutes followed
by 30 min and 2 h of reperfusion (Mirro et al., 1991) may have represented a more severe
ischemic insult compared with the hypotensive-hypoxia/hypercarbia insult on our previous
study (Stonestreet et al., 1992). In addition, activated oxygen species appear to contribute to
the ischemia-reperfusion related barrier dysfunction in the newborn pigs (Armstead et al.,
1992). The response of the blood-brain barrier to hypoxia-ischemia also appears to vary in
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young rodents depending upon the duration of reperfusion and the age at the insult
(Muramatsu et al., 1997).
Although biphasic opening of the blood-brain barrier after middle cerebral artery occlusion
(MCAO) has been reported in adult rats (Kuroiwa et al., 1985, Belayev et al., 1996), the
temporal and spatial pattern of blood-brain barrier abnormalities after ischemia has not been
delineated in the fetus. The effectiveness and integrity of the tight junction seal between
adjacent endothelial cells has been suggested to be critical to the homeostasis of the CNS in
response to hypoxic-ischemic brain injury (Vaccarino and Ment, 2004). Although
information regarding the effects of hypoxia-ischemia on the regulation of tight junctions in
the immature brain is sparse, particularly in vivo, we have previously shown increased
expression of claudin-5, decreased expression of ZO-1 and -2, and stable levels of occludin
and claudin-1 measured 72-h after ischemia in fetal sheep (Malaeb et al., 2007).
In the current study, we examined the effects of reperfusion for 4-, 24-, or 48-h after 30
minutes of ischemia on blood-brain barrier function measured quantitatively with the blood-
to-brain transfer constant (Ki) and ischemia/reperfusion effects on tight junction proteins by
Western immunoblot on fetal sheep brains harvested at 127 days-of-gestation. Given the
above considerations, we hypothesized that 1) increases in blood-brain barrier permeability
after ischemia depend upon the duration of reperfusion and that 2) decreases in tight
junction proteins are associated with the ischemia-related impairment in blood-brain barrier
function in the fetus.
EXPERIMENTAL PROCEDURES
The present study was conducted after approval by the Institutional Animal Care and Use
Committees of the Alpert Medical School of Brown University and Women & Infants
Hospital of Rhode Island and in accordance to the National Institutes of Health Guidelines
for the use of experimental animals.
Animal Preparation, Study Groups, and Experimental Design
Surgery was performed under 1–2% isoflurane anesthesia on 20 mixed breed pregnant ewes
at 120 to 122 days-of-gestation as previously described (Petersson et al., 2002). Briefly,
polyvinyl catheters were placed in fetal brachial veins and arteries and in the femoral artery
of the ewe for blood pressure and heart rate monitoring, as well as blood sampling
(Petersson et al., 2002). An amniotic fluid catheter was placed as a referent for fetal arterial
pressures.
The fetal carotid arteries were exposed, vertebral-occipital anastomoses and lingual arteries
ligated to restrict blood flow from the vertebral circulation and non-cerebral blood flow,
respectively (Gunn et al., 1997). Two inflatable 4-mm vascular occluders (In Vivo Metric,
Healdsburg, CA, USA) were placed around each carotid artery and ultrasonic flow probes
(Transonic Systems Inc., Ithaca, NY, USA) between the heart and occluders. To measure the
fetal electrocorticogram (ECoG), two pairs of screws (Small Parts, Inc., Miami Lakes, FL,
USA) were placed onto the dura with a reference electrode sewn to the scalp (Gunn et al.,
1997) and connected to the recorder (ADInstruments, Colorado Springs, CO, USA) with
insulated wires (Alpha Wire Co., Elizabeth, N.J., USA).
After recovery from surgery at 125–130 days of gestation, the ewes were assigned to four
groups: instrumented non-ischemic sham-control treated (non-ischemic, n=5), 30-minutes of
carotid occlusion, hereafter designated as ischemia, and 4-h reperfusion (I/R-4, n=5),
ischemia and 24-h reperfusion (I/R-24, n=5), or ischemia and 48-h reperfusion (I/R-48,
n=5). To minimize unnecessary animal usage, three-instrumented non-ischemic control fetal
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sheep e.g. undergoing full surgical procedures but without carotid artery occlusion, exposed
to 24-h of reperfusion and two-instrumented non-ischemic fetal sheep exposed to 48-h of
reperfusion were studied. There were no differences in blood-brain barrier permeability or
tight junction protein expression between the two control groups. Therefore, the non-
ischemic control animals were pooled for a total n=5. Full term gestation for the breed of
sheep used in our study is 148 days of gestation according to the supplier (Purdue, Lafayette,
IN). Thus, the fetal sheep were studied at approximately 85% of gestation in this study.
Although the relative maturation of ovine and human brains cannot be precisely compared,
the sheep brain at 80–85% of gestation is generally thought to be similar to the near term
human infant (Gunn et al., 1997).
Thirty-minutes of ischemia was induced by inflating the occluders. At the conclusion of
ischemia, the occluders were deflated and reperfusion continued for 4-, 24-, or 48-h. Study
of blood-brain barrier permeability was performed over 1-h in each group at the conclusion
of reperfusion. The ewe and fetus were then euthanized by intravenous pentobarbital (100–
200 mg/kg). The fetus was weighed, sex determined, and the brain quickly removed and
weighed. One-half of the fetal brain was dissected for regional blood-brain barrier
permeability analysis as previously described (Stonestreet et al., 1996), and the remainder
frozen for tight junction protein expression analysis.
Analytic Methods
Blood-brain barrier function was measured with α-[14C]-aminoisobutyric acid (AIB, 103
Da, American Radiolabeled Chemicals, Inc. St. Louis, MO, USA) as previously described in
detail (Stonestreet et al., 1996). Briefly, α-[14C]-AIB (27.6±5.7 µCi/kg, mean ± SD) was
rapidly injected intravenously and arterial plasma α-[14C]-AIB concentrations obtained at
intervals both before and after injection.
Brain vascular volume was determined by administering technetium-99m-(99mTc)
radiolabeled red blood cells (RBCs) to the fetus two minutes before the end of the studies
(Stonestreet et al., 1989a, Stonestreet et al., 1996). Four ml of whole blood obtained from
the ewe was drawn into a syringe containing 0.8 ml of acid citrated-dextrose, incubated with
Tinpyrophosphate for 15 minutes, and with 99mTc (Cardinal Health, RI) for an additional 15
minutes (Stonestreet et al., 1989a). The 99mTc-labeled RBCs were washed, resuspended in
0.154 M NaCl to a volume of 4 ml, and administered intravenously to the fetus. The
radiolabeling efficiency of the RBCs exceeded 99%. We used radiolabeled-RBCs in these
studies rather than polyethylene glycol (Stonestreet et al., 1996) to avoid potential leakage of
the small molecular weight substances from the brain vasculature after ischemia.
Fetal brains were dissected into the following regions: cerebral cortex (frontal, parietal, and
occipital), white matter, caudate nucleus, hippocampus, cerebellum, thalamus, superior
colliculus, inferior colliculus, pons, medulla, spinal cord, and pituitary gland. Plasma and
tissue samples were prepared and radioactivity quantified for α-[14C]-AIB (Stonestreet et
al., 1996). Knowledge of the plasma concentration profile and tracer concentration in the
parenchyma allows calculation of the blood-to-brain transfer constant (Stonestreet et al.,
1996):
Where Abr is the amount of tracer that crossed the blood-brain barrier from blood to brain
during the tracer study (dpm•g−1), and cp is the tracer concentration in plasma (dpm•µl−1) at
the time t (min). Abr is obtained by correcting the total amount of isotope measured in the
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tissue Am (dpm•g−1) for the residual part remaining in the brain vasculature space, which is
measured by 99mTc-labeled RBCs. Thus, Abr = Am-Vpcp, where Vp is the blood volume of
brain tissue (µl•g−1) and cp is the concentration of tracer in the terminal plasma sample
(dpm•g−1). Vp = A†m/c†p, where A† m and c†p have the same definitions as Am and cp
above except that they apply to the 99mTc-labeled RBCs (Stonestreet et al., 1996)
Fetal arterial blood gases, pH, heart rate, arterial blood pressure (MABP) hematocrit, lactate,
and osmolarity values were measured at baseline, and sequentially after the end of ischemia.
ECoG and carotid arterial blood flow were obtained at baseline, and during and after
ischemia. Blood gases and pH were measured on a blood gas analyzer (model 248, Siemens,
Washington, DC) corrected to 39.5°C for fetuses and 38.5°C for ewes. The ECoG was
amplified, filtered, and recorded on a PowerLab Data Acquisition System (ADInstruments,
Colorado Springs, CO). Carotid arterial blood flow was measured with the flow probes and
recorded (Small Animal Blood Flow Meter: T206, Transonic Systems Inc. Ithaca, NY).
Although carotid blood flow does not directly measure brain blood flow, carotid arterial and
brain blood flow are closely related (van Bel et al., 1994). Carotid arterial blood flow was
the sum of left and right carotid arterial blood flow averaged over 5-minutes at each
measurement time.
ECoG Processing
All ECoG files were visually inspected by a board certified epileptologist (J.G.), who was
not aware of the group identity. The recorded ECoG signals were digitized (16 bits, 1000
Hz) and stored. Signal processing was performed off line with MATLAB® (Mathworks,
Natick, MA) on data segments from the baseline, ischemia, and reperfusion periods and
during sham-control treatment, which were extracted from the ECoG recordings of each
fetus. The duration of each ECoG segment averaged 15 minutes in each of the four groups.
The length of the analyzed ECoG segments did not differ among the groups. We first
analyzed the ECoG data to determine the frequency range that suggested the largest
differences among the study periods i.e. baseline, ischemia, and reperfusion. The grand
average power spectral densities (PSD) were used to estimate the frequency ranges.
Preliminary examination of five sheep exposed to ischemia and reperfusion for 4-h
suggested that a discriminatory frequency band of 10–100 Hz was optimal for subsequent
analysis. Then, to calculate the power of the extracted data, segments in this band were
subdivided into ten-second non-overlapping windows. A 10-sec window was selected based
upon requirements for the window to be long enough for accurate power analysis estimates
and short enough to eliminate potential artifacts. A fifth order Butterworth band pass filter of
10–100 Hz and a 60 Hz notch filter were applied to each window. The window mean was
subtracted and the variance of the de-meaned windows used as the window power because
the power of a sample with a zero mean is equal to the sample variance (Shiavi, 2007). The
overall power of each segment was calculated as an average power for the windows within
the segment that did not contain discontinuities caused by artifacts. The power of the
segments was normalized to a zero mean and unit standard deviation for each fetus to
account for offset power differences among the fetuses. Finally, the baseline power for each
group was subtracted from the power for the rest of the segments before analysis.
Protein Extraction
Cell membrane fractions of the cerebral cortical, cerebellar, and hippocampal samples for
occludin, claudin-1 and claudin-5 protein analyses were extracted in Triton/Deoxycholate/
Sodium-dodecyl-sulfate (100 mM NaCl, 1% Triton-X, 0.5 sodium deoxycholate, 0.2%
sodium-dodecyl-sulfate (SDS), 2 mM EDTA, and 1 mM benzamidine) with 1% complete
protease inhibitor cocktail (Roche, Nutley, NJ). The cytosolic cell fraction for ZO-1 and
ZO-2 was extracted in urea buffer (6 M urea, 150 mM NaCl, 5 mM MgCl2, 5 mM EGTA,
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10 mM Tris, pH 8.0, and 1% Triton-X) with 1% complete protease inhibitor cocktail. Total
protein concentrations of the homogenates were determined with a bicinchoninic acid
protein assay (BCA, Pierce, Rockford, IL).
Western Immunoblot Detection and Quantification of Proteins
Fifty µg of total protein per well were fractionated by SDS-PAGE electrophoresis and
transferred onto PVDF membranes (0.2 micron, Bio-Rad Laboratories, Hercules, CA) using
a semi-dry technique. Membranes were incubated with primary antibodies: mouse occludin
monoclonal antibody (mAb, Zymed, San Francisco, CA) at a dilution of 1:2500; mouse
claudin-1 mAb (Zymed) at a dilution of 1:6000; mouse claudin-5 and ZO-1 mAbs (Zymed)
at a dilution of 1:5000 and mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mAb (Imgenex, San Diego, CA) at a dilution of 1:5000; and rabbit ZO-2 polyclonal
antibody (Zymed) at a dilution of 1:5000. Peroxidase-labeled secondary antibodies were
used: goat anti-mouse secondary antibodies (Zymed) at dilution of 1:5000 for occludin,
1:10,000 for claudin-1, claudin-5, ZO-1 and GAPDH, and goat anti-rabbit secondary
antibody (Zymed) at a dilution of 1:10,000 for ZO-2.
All experimental samples were normalized to a reference protein standard that was obtained
from a homogenate protein pool from the cerebral cortex of a single adult sheep. As we
previously described, these samples served as an internal control reference standard for
quality control of loading, transfer, verification of potential internal variability across the
gels, and for normalization of cerebral cortical, cerebellar and hippocampal densitometric
values to permit accurate comparisons against a single internal control standard among the
different groups and immunoblots (Malaeb et al., 2007). The same internal control sample
was used for each tight junction protein on all immunoblots, thereby minimizing potential
differences among immunoblots due to loading, transfer, and autoradiographic densitometric
measurements. The experimental tight junction protein densitometrical values were
expressed as a ratio to the internal control samples, facilitating normalized comparisons
among the different groups and immunoblots. In addition, GAPDH expression was also used
as a loading control to ensure that equal amounts of protein had been applied to each lane.
However, the experimental protein bands were not normalized to the GAPDH, rather as
described above and previously (Kim et al., 2006, Malaeb et al., 2007), the experimental
protein bands were normalized to the internal control samples to facilitate comparisons
among the multiple immunoblots for the 20 control and experimental subjects in the current
study.
Each immunoblot included samples from the four groups and three internal control samples.
The internal control samples were included in three lanes, as the first, middle, and last
samples on each immunoblot. A coefficient of variation for the internal control samples on
each immunoblot was calculated. The values for the experimental samples were considered
valid only if the percent coefficient of variation for the internal control samples was less
than 20% on each immunoblot. We have previously shown that this method correlates with
values that were normalized as ratios to β-actin (Kim et al., 2006) and have published this
procedure extensively (Kim et al., 2006, Malaeb et al., 2007). The extracts from the cerebral
cortex, cerebellum, and hippocampus from 20 fetal sheep were placed on different
immunoblots. Therefore, to facilitate graphic clarity in Fig. 3 and 4, we selected the
immunoblot that most closely represented the mean values for each group.
We also examined the relative expression of each tight junction protein among the cerebral
cortical, hippocampal and cerebellar brain regions within the non-ischemic group to
determine if there were any differences in protein expression among these brain regions
under basal conditions as we have previously described (Sadowska et al., 2009).
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Madin-Darby canine kidney cell lysate (MDCK, Canine Kidney Carcinoma, BD
Biosciences, San Diego, CA) was used as a positive control for occludin, claudin-1, and
ZO-1 and ZO-2, and rat lung for claudin-5 (Malaeb et al., 2007). Positive controls were used
on the same immunoblot as sheep brain samples to establish that the tight junction proteins
identified by the antibodies were the same as the known protein for which the antibodies
were specific. Detection of occludin, claudin-1, claudin-5, ZO-1, and ZO-2 bands at 65, 22,
22, 225, and 160 kDa, respectively, was dependent on incubation with primary antibody,
omission of which resulted in the absence of this signal.
Densitometric Analysis
Band intensities were analyzed with a Gel-Pro Analyzer (Media Cybernetics, Silver Spring,
MD, USA). Experimental samples were normalized to the average of the three respective
internal control samples on each immunoblot. The final values for each protein in each brain
region represented an average of the densitometry values from at least two different
immunoblots (range 2–6) and were presented as a ratio to the internal control sample.
Statistical Analysis
Results are expressed as mean ± standard deviation (SD), with the exception of the ECoG,
which are expressed as median ± SD. The median for the ECoG was used due to the larger
effect of movement on the mean. Two-factor analysis of variance (ANOVA) was used to
compare ECoG recordings from the ischemia and reperfusion study periods that were
normalized to the baseline ECoG values between the sham-control and ischemic-reperfusion
groups. In view of the fact that all the animals were subjected to 30 min ischemia, data from
I/R-4, I/R-24 and IR-48 groups were pooled into one I/R group for analysis and graphic
presentation of ECoG and carotid blood flow. Repeated measures two-factor ANOVA was
used to compare carotid blood flow and regional blood-brain barrier permeability within and
between the groups. One-way ANOVAs were used to detect differences among the three
brain regions for each tight junction protein examined. If a significant difference was found
by ANOVA, the Fisher LSD test was used to detect specific differences among the study
groups and brain regions. Stepwise multiple regression analysis was used to compare
associations between changes in blood-brain barrier permeability and tight junction protein
expression under the different reperfusion duration conditions. Because the non-ischemic
and ischemia-reperfusion groups received different treatments, these different categorical
variables were accounted for by applying a dummy coding variable in the multiple
regression analyses (Pedharzur, 1973, Stonestreet et al., 1989b). A value of P<0.05 was
considered statistically significant.
RESULTS
Differences in gestational age (F=0.60, P=0.62), brain weight (F=0.83, P=0.50), or body
weight (F=0.59, P=0.63) were not observed among the non-ischemic, I/R-4, I/R-24, and I/
R-48 groups (Table 1). The arterial pH, PO2 and PCO2, heart rate, MABP, lactate,
hematocrit, and osmolarity values were within the normal physiologic range for our
laboratory (Stonestreet et al., 1993), and did not change during the study periods within or
between groups (Table 2).
ECoG and Carotid Blood Flow
The ECoG analysis and carotid blood flow values were determined to verify that ischemic
exposure was adequate in the fetuses, regardless of the differences in duration of
reperfusion. This was confirmed by ECoG attenuation and carotid blood flow values
approaching zero during ischemia (Fig. 1A and B). On visual inspection of the ECoG
signals (J.G.), the three I/R groups demonstrated similar attenuations of greater than 50%
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from the baseline amplitude values during ischemia, whereas the non-ischemic fetuses did
not exhibit any amplitude attenuation during sham treatment (F=0.54, P=0.49, Data not
shown). The grand average power spectral density (PSD-ECoG) signals demonstrated
significant reductions from baseline values during ischemia (F=26.26, P<0.05, Fig. 1A).
However, after ischemia, the ECoG values returned to values that were similar to baseline
values and did not differ between non-ischemic and ischemia-reperfusion groups (F=1.28,
P=0.31). The carotid arterial blood flow values approached zero within one minute after the
onset of ischemia, and remained in this range for the 30-minutes duration of ischemia and
also returned to values that did not differ from baseline after ischemia (Fig. 1B).
Blood-Brain Barrier Permeability (Ki) Measurements
The Ki values were significantly higher across brain regions in fetuses of the I/R-4, I/R-24,
and I/R-48 groups than in the non-ischemic group indicating that reperfusion for 4-, 24- and
48-h resulted in increases in blood-brain barrier permeability (F=10.6, P<0.05, Fig. 2). The
Ki values were also higher across brain regions in fetuses of the I/R-4 group than in the I/
R-24 (F=10.2, P<0.05) and I/R-48 (F=6.1, P<0.05) groups suggesting that the Ki values
were highest at 4-h after ischemia. There were no differences across brain regions between
the I/R-24 and I/R-48 groups, suggesting that the increases in Ki values were similar at 24-
and 48-h after ischemia (F=0.5, P=0.5). The sex of the fetuses did not influence the Ki
values as a function of length of reperfusion (F=0.07, P=0.80).
The magnitude of the increases in permeability after ischemia was not uniform across brain
regions within the I/R-4 (F=16.6, P<0.05), I/R-24 (F=22.5, P<0.05) and I/R-48 (F=14.6,
P<0.05) groups (Fig. 2) suggesting that there was a heterogeneity in the responses among
different brain regions to ischemia-reperfusion. Inspection of Fig. 2 suggests that the largest
increases appear in the caudal brain structures including cerebellum, inferior colliculus,
pons, medulla, and spinal cord.
The Ki values were also higher across the cerebral cortical regions in fetuses in the I/R-4, I/
R-24, and I/R-48 groups than in the non-ischemic group (F=11.8, P<0.05, Fig. 3). The Ki
values were higher in the parietal and occipital cortices of the I/R-4 group (P<0.05) and in
the occipital cortex of the I/R-48 (P<0.05) group than in the non-ischemic group.
The pituitary gland is an intracranial structure lacking a blood-brain barrier (Stonestreet et
al., 1996). Consistent with our previous work (Stonestreet et al., 1996), Ki values in the
pituitary gland were much higher than in other intracranial structures (20.7±4.21, 28.6±5.69,
28.8±2.96, and 25.8±7.42 µl•g Brain−1•min−1 in non-ischemic, I/R-4, I/R-24, and I/R-48
groups, respectively). The considerably higher permeability in this structure compared with
other brain regions further validates the Ki values as measures of blood-brain barrier
permeability in brain regions known to possess tight blood-brain barrier properties. The
pituitary gland Ki values were higher in the fetuses of the I/R-4, I/R-24, and I/R-48 groups
than in the non-ischemic group (F=7.41, P<0.05) suggesting that even though the pituitary
gland lacks a tight blood-brain barrier, its permeability still increases after ischemic-
reperfusion injury.
Blood Volume Measurements
Table 3 contains the blood volume values in the brain regions of all groups. Blood volume
was higher in the cerebral cortex of the I/R-24 group than in the non-ischemic and I/R-4
groups, and in the I/R-48 group than in the I/R-4 group (F=3.37, P<0.05). Regional blood
volume was higher in white matter of the I/R-24 group than in the non-ischemic and I/R-48
groups (F=3.29, P<0.05), and in the cerebellum of I/R-24 and I/R-48 groups than in I/R-4
group (F=5.71, P<0.01). Differences were not observed in the blood volume of other brain
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regions among the groups (caudate nucleus: F=1.96, P=0.16; hippocampus: F=2.96, P=0.06;
inferior colliculus: F=0.74, P=0.54; medulla: F=2.88, P=0.07; pons: F=1.17, P=0.35;
superior colliculus: F=1.37, P=0.29; spinal cord: F=1.21, P=0.34; thalamus: F=0.88,
P=0.47). Therefore, ischemic-reperfusion-related brain injury is associated with a relatively
limited number of changes in regional blood volume in fetal brain. As expected, the blood
volume values measured with RBCs were slightly lower than plasma volumes measured
with polyethylene glycol, molecular weight=4000 (Stonestreet et al., 1996).
Tight Junction Protein Expression
Occludin expression was lower (P<0.05) in cerebral cortex (F=5.1), hippocampus (F=3.5),
and cerebellum (F=3.4) of the I/R-4 group than in the non-ischemic group, higher (P<0.05)
in these regions in the I/R-24 group than in the I/R-4 group, and higher (P<0.05) in the
cerebral cortex and cerebellum of the I/R-48 group than in the I/R-4 group (Fig. 4 A). In
contrast, claudin 1 expression was higher in the hippocampus (F=4.4, P<0.05) of the I/R-24
and I/R-48 groups than in the non-ischemic group, and in the cerebellum (F=19.4, P<0.05)
of the I/R-4 group than in the non-ischemic group, lower (P<0.05) in the cerebellum of the I/
R-24 and I/R-48 groups than in the I/R-4 group, and did not differ in the cerebral cortex
(F=0.20, P=0.86) among groups (Fig. 4 B). Claudin-5 expression was lower (P<0.05) in
cerebral cortex (F=4.0), hippocampus (F=6.28), and cerebellum (F=3.6) of the I/R-4 group
than in the non-ischemic group, and higher (P<0.05) in these regions of the I/R-24 than I/
R-4 group, but did not differ between the I/R-48 and I/R-4 groups (Fig. 4 C). Therefore,
occludin and claudin-5 expression were lower in the I/R-4 group than in the non-ischemic
group, but tended to return toward values similar to the non-ischemic group by 24- and 48-h
after ischemia.
ZO-1 is expressed as two isoforms due to alternative RNA splicing (Kurihara et al., 1992).
Although we identified two ZO-1 protein bands in some brain regions, the densitometry
values for the two bands were not distinct enough in all of the groups to permit accurate
analysis of the separate bands. Hence, the densitometry values of the two ZO-1 bands were
combined for analysis. Likewise, the multiple bands of ZO-2 were combined. ZO-1 and
ZO-2 expression were lower in cerebral cortex, hippocampus, and cerebellum of the I/R-4, I/
R-24 and I/R-48 groups than in the non-ischemic group (ZO-1: F=5.8, F=14.3, and F=24.0,
P<0.05; ZO-2: F=3.3, F=3.7, and F=6.2, P<0.05, in the cerebral cortex, hippocampus, and
cerebellum, respectively; Fig. 5 A and B). Differences in ZO-1 and ZO-2 expression were
not observed among the I/R-4, I/R-24, and I/R-48 groups (ZO-1: F=1.17, F=3.19, and
F=1.72, P>0.05; ZO-2: F=0.20, F=0.04, and F=1.19, P>0.05, in the cerebral cortex,
hippocampus, and cerebellum, respectively).
We also examined the relative expression of each tight junction protein in the cerebral
cortex, hippocampus, and cerebellum within the non-ischemic group to determine if there
were any differences in tight junction protein expression among these brain regions under
basal conditions (Sadowska et al., 2009). Occludin, claudin-5, ZO-1, and ZO-2 expression
was higher in the cerebellum than the cerebral cortex and hippocampus (F=92.4, F=22.1,
F=487.8, and F=99.7, P<0.05 for occludin, claudin-5, ZO-1, and ZO-2, respectively, Fig. 4
and 5). In contrast, claudin-1 expression was lower in the cerebellum than cerebral cortex
and hippocampus (F=56.1, P<0.05, Fig. 4).
Correlational Analysis between Regional Blood-Brain Barrier Permeability and Tight
Junction Proteins
The Ki values demonstrated an inverse linear correlation with claudin-5 expression in the
cerebral cortex (Fig. 6), with occludin, claudin-5, ZO-1 and ZO-2 in the hippocampus, and
with ZO-1 or ZO-2 in the cerebellum (Table 4), but not with occludin, claudin-1, ZO-1 or
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ZO-2 in the cerebral cortex, claudin-1 in hippocampus, or occludin, claudin-1, or claudin-5
in the cerebellum. The inverse correlations between Ki and tight junction proteins suggest
that decreases in the tight junction proteins are associated with the increases in blood-brain
barrier permeability.
DISCUSSION
The purpose of this study was to examine the effects of different durations of reperfusion
after ischemic brain injury on blood-brain barrier function and tight junction protein
expression in ovine fetuses. Although previous studies have investigated the time course of
blood-brain barrier dysfunction after ischemia in adult subjects (Strbian et al., 2008),
information regarding the structure and function of the blood-brain barrier in the immature
brain is sparse, particularly under pathological conditions. There is no previous quantitative
data measuring blood-brain barrier permeability (Ki) after ischemia in the fetus, particularly
not in the brain of a precocial species such as the sheep. Moreover, there are methodological
discrepancies among studies of adult subjects, including differences in animal species, the
use of a variety of different tracers, in tracer circulation times, lengths of ischemia, and
durations of reperfusion (Kuroiwa et al., 1985, Belayev et al., 1996, Neumann-Haefelin et
al., 2000, Strbian et al., 2008). In the current study, we achieved near complete cessation of
carotid arterial blood flow for 30-minutes and documented attenuation of the ECoG
amplitude, thereby establishing efficacy of the insult. Our findings are as follows. 1)
Ischemia with reperfusion for 4-, 24-, or 48-h impaired blood-brain barrier function. 2) The
largest increase in permeability occurred 4-h after ischemia. 3) The blood-brain barrier
appears less permeable at 24- and 48-h after ischemia suggesting that barrier function
improves relatively soon after injury. 4) Changes in the molecular composition of tight
junctions are associated with increases in blood-brain barrier permeability after ischemia in
the fetus. Impaired barrier function represents a major unappreciated component of hypoxic-
ischemic brain injury in the fetus, particularly early after the insult, and thus could represent
a potential therapeutic target.
The biochemical and hemodynamic values measured in our study did not differ from
baseline values among or within the non-ischemic and ischemic-reperfusion groups. Carotid
blood flow and ECoG did not differ from the baseline values in the fetuses of ischemic-
reperfusion groups after ischemia. Therefore, our findings suggest that prolonged intervals
of reperfusion after ischemic brain injury may not have a major impact upon systemic
biochemical, metabolic, and hemodynamic homeostasis in fetal sheep. We also documented
small differences in blood volume values of some brain regions among groups (Table 3).
However, these differences do not account for ischemia-reperfusion related permeability
changes because they were modest, occurred only in a few brain regions, and the Ki
calculations account for the residual AIB remaining in the vascular space at the end of the
studies (Stonestreet et al., 1996).
Our findings demonstrating the largest increase in permeability occurred 4-h after ischemia
in fetal sheep, are consistent, in part, with findings in adult rats after traumatic brain injury
(Baskaya et al., 1997). A biphasic pattern of blood-brain barrier opening has been reported
in adult rodents (Belayev et al., 1996, Baskaya et al., 1997, Huang et al., 1999). Early
opening occurs between 25-minutes (Strbian et al., 2008) and 6-h (Baskaya et al., 1997,
Dimitrijevic et al., 2006) after ischemia, with a second delayed barrier opening between 5-
and 72-h (Kuroiwa et al., 1985), between 22- and 46-h (Huang et al., 1999), and at 24-h
(Dimitrijevic et al., 2006), 48-h (Belayev et al., 1996, Rosenberg et al., 1998), and 72-h (Jiao
et al., 2011) after ischemia in adult rodents. However, we did not observe this pattern in our
fetal sheep. Although blood-brain barrier permeability was lower at 24- and 48- than at 4-h,
values were not similar to the non-ischemic group. However, we speculate that the
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decreased barrier permeability at 24- and 48-h compared with 4-h of reperfusion suggests
partial restitution of barrier function could begin relatively soon after an ischemic insult in
the fetus.
The response to ischemia-reperfusion was not homogenous among all brain regions. Similar
to our previous findings (Stonestreet et al., 1996), inspection of regional permeability
suggests that the permeability in all study groups was heterogeneous, and more pronounced
in the caudal than rostral brain regions (Fig. 2). This observation could be in part attributable
to increased permeability of the circumventricular organs in more caudal brain regions
(Morita and Miyata, 2012). Some of these regions are also more vulnerable to hyperosmolar
stress during development (Stonestreet et al., 2006). Hence, it appears that there could be an
increased susceptibility of specific brain regions to ischemia-reperfusion in the immature
brain.
The mechanism(s) responsible for blood-brain barrier dysfunction after ischemic injury have
not been completely elucidated and could involve all components of the neurovascular unit
(Abbott, 2000). Armstead et al., reported that the activated oxygen generation contributes to
increased barrier permeability after ischemia/reperfusion in newborn pigs and that oxygen
free radical scavengers partially attenuate the increased permeability associated with
ischemia/reperfusion (Armstead et al., 1992). In addition, tight junction proteins are known
to restrict movement of substances through paracellular pathways between adjacent
endothelial cells (Hawkins and Davis, 2005) and ischemic-reperfusion injury is known to
induce opening, cellular redistribution, and alterations in tight junction protein expression
(Cipolla et al., 2004). We found significant differences in the response of transmembrane
and associated cytoplasmic proteins to different durations of reperfusion. Overall,
expression patterns of occludin and claudin-5 were similar, showing a decrease 4-h after
ischemia and a return to values similar to those in the non-ischemic group by 24- and 48-h
after ischemia. Our findings are consistent with results in adult rodents examining the effects
of 3-h of reperfusion after 90-minutes of MCAO (Yang et al., 2007) and 3-h of reperfusion
after 2-h of MCAO on occludin and claudin-5 expression in microvascular endothelial cells
(Jiao et al., 2011), but differ from results in which occludin and claudin-5 expression
decreased between 3- and 120-h after ischemia (Jiao et al., 2011). Likewise, the decreased
ZO-1 and ZO-2 expression 4-, 24-, and 48-h after ischemia are consistent with findings in
adult rodents, in which ZO-1 expression decreased between 3- and 120-h after 2-h of
MCAO (Jiao et al., 2011). Moreover, we have shown that 72-h after the same insult,
claudin-5 expression actually increased, whereas ZO-1 and ZO-2 remained reduced in the
cerebral cortex of fetal sheep (Malaeb et al., 2007). Taken together, our results suggest that
restitution of occludin and claudin-5 expression begins relatively soon after ischemia and
represents a continuum to increased expression 72-h after ischemia. However, the
cytoplasmic associated proteins, ZO-1, and ZO-2, remain reduced for 72-h after ischemia in
the fetal sheep brain.
In contrast, claudin-1 exhibited a very different expression pattern after ischemia. Similar to
findings after hypoxia-reoxygenation (Mark and Davis, 2002), claudin-1 expression
remained similar to the non-ischemic group in cerebral cortex, but increased 24- and 48-h
after ischemia in hippocampus, and 4-h after ischemia in cerebellum. Although the higher
claudin-1 expression after ischemia was not expected, it has recently been reported that
blood-brain barrier leakiness was reduced around vessels expressing claudin-1 in a model of
experimental autoimmune encephalomyelitis (Pfeiffer et al., 2011). Hence, the higher
claudin-1 expression that we observed could potentially support the partial improvement of
blood-brain barrier function observed in the hippocampus 24- and 48-h after ischemia (Fig.
2 and 3), but does not explain the higher permeability and claudin-1 expression in the
cerebellum 4-h after ischemia. Thus, the response of the tight junction proteins to ischemia-
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reperfusion insult varies with respect to the specific protein, brain region, and duration of
reperfusion.
It is also important to point out that the changes in the tight junction proteins occurred
relatively rapidly after ischemia. The mechanisms underlying these changes cannot be
discerned by our study but could involve multiple factors including the selective loss of
certain proteins, suggesting rapid degradation, or could result from overall damage to
endothelial cells, and/or interactions with other components of the neurovascular unit such
as astrocytes and basement membranes (Abbott, 2000). Alternatively, other binding proteins
could sequester tight junction proteins immediately after ischemia, and later release them.
Furthermore, we found increases in blood-brain barrier permeability were associated with
decreases in claudin-5 expression in cerebral cortex and hippocampus, decreases in occludin
in hippocampus, and decreases in ZO-1 and ZO-2 in hippocampus and cerebellum (Fig. 6;
Table 4). Therefore, decreases in tight junction protein expression in the fetal brain after
ischemia could have functional consequences. These findings are important as claudin-5
forms the primary “seal” of the tight junction restricting transfer of low molecular weight
molecules from blood to brain (Honda et al., 2006), and occludin acts as a support molecule
modulating tight junction function (Hawkins and Davis, 2005). The inverse linear
correlations between increases in permeability and decreases in ZO-1 and ZO-2 protein
expression in the hippocampus and cerebellum are consistent with previous studies of
hypoxia-induced increases in paracellular permeability and decreases in ZO-1 and ZO-2
expression (Mark and Davis, 2002, Fischer et al., 2004). The continued reductions in ZO-1
and ZO-2 expression up to 72-h (Malaeb et al., 2007) after ischemia could contribute to
persistently impaired barrier function because ZO-1 and ZO-2 are scaffolding proteins
providing the structural basis for coupling transmembrane tight junction proteins to the
cytoskeleton (Hawkins and Davis, 2005, Jiao et al., 2011). Consistent with our findings
Lenzser et al. reported, the loss of occludin protein correlated well with increased barrier
permeability 48 h after ischemia in adult rats (Lenzser et al., 2007). Moreover, loss of
occludin protein was accompanied by the presence of lower molecular weight degradative
proteins on Western immunoblot, and the increase in this low molecular weight protein
correlated with the loss of occludin protein (Lenzser et al., 2007).
There are several limitations to our study. We were only able to examine a limited number
of animals per group in this large mammalian species and determined permeability at a three
time points after ischemia. Hence, we cannot comment upon potential changes in
permeability between 4 and 24 h after ischemia, nor can we comment upon the long-term
recovery after ischemia.
CONCLUSIONS
Impaired blood-brain barrier function is an important component of hypoxic-ischemic
injury, particularly early after insults to the fetal brain. Ischemia/reperfusion of a specific
duration results in variable changes in the levels of tight junction proteins that may be
associated with changes in blood-brain barrier permeability. Changes in the molecular
composition of tight junction proteins are associated with increases in barrier permeability
after ischemia in the fetal brain and could represent a potential therapeutic target for the
treatment of hypoxia-ischemia. Contributions of blood-brain barrier abnormalities to
hypoxic-ischemic brain injury have not been fully appreciated in the fetus. Barrier
dysfunction, particularly early after an insult, could potentially exacerbate brain damage by
facilitating the entry of blood borne substances into the brain.
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Blood-brain barrier permeability increases after ischemia-reperfusion in the fetus.
Increases in permeability (Ki) change as function of the duration of reperfusion.
Tight junction (TJ) protein expression decreases after ischemia in fetal brain.
TJ protein decreases are associated with ischemia-related increases in permeability.
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Figure 1.
ECoG (A) and carotid blood flow (B) plotted for the non-ischemic (n=4 up to 24-h and n=2
up to 48-h because the ECoG in one animal at 24-h was not adequate, and n=5 up to 24-h
and n=2 up to 48-h for ECoG and carotid blood flow, respectively), I/R group includes I/
R-4, n=5, I/R-24 n=5, and I/R-48, n=5 plotted against study time in hours, before ischemia
at baseline, and during ischemia and reperfusion. ECoG (A) Y-axis is the normalized ECoG
power as difference from the individually averaged baseline ECoG values. Values are
median ± SD and mean ± SD for ECoG and carotid arterial blood flow, respectively. When
n=2, values plotted as separate symbols rather than means. (A) *P<0.05 ischemia vs.
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baseline within I/R group, but not non-ischemic group and (B) *P<0.05 ischemia vs.
baseline within I/R group.
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Figure 2.
Blood-to-brain transfer constants (Ki) in the non-ischemic (n=5), I/R-4 (n=5), I/R-24 (n=5),
and I/R-48 (n=5) groups plotted for 11 brain regions. Values are mean ± SD. *P<0.05 vs.
nonischemic group, + P<0.05 vs. I/R-4 group.
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Figure 3.
Blood-to-brain transfer constants (Ki) in the non-ischemic (n=5), I/R-4 (n=5), I/R-24 (n=5),
and I/R-48 (n=5) groups plotted for the frontal, parietal and occipital cerebral cortices.
Values are mean±SD. *P<0.05 vs. non-ischemic group.
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Figure 4.
Tight junction protein expression in the cerebral cortex, hippocampus, and cerebellum.
Group legends and numbers as for figure 2. A. Occludin, B. Claudin-1, and C. Claudin-5.
Representative Western immunoblot shown for each tight junction protein; IC indicates the
internal control standard protein derived from the same adult cerebral cortex. The extracts
from the cerebral cortex, hippocampus, and cerebellum from the different treatment groups
were placed on different immunoblots. Therefore, for the purpose of illustration, the
immunoblot that most closely represented the mean value of the bar graph for each protein
and brain region of each group was selected for illustration above the bar graph. GAPDH is
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also shown as a loading control. Values are expressed as mean ± SD. *P <0.05 vs. non-
ischemic group, + P <0.05 vs. I/R-4 group.
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Figure 5.
Tight junction protein expression in the cerebral cortex, hippocampus, and cerebellum.
Group legends and numbers as for figure 2. A. ZO-1, B. ZO-2 in the non-ischemic, I/R-4, I/
R-24, and I/R-48 groups. Representative Western immunoblot shown for each tight junction
protein; IC indicates the internal control standard protein derived from the same adult
cerebral cortex. Values are expressed as mean ± SD. *P <0.05 vs. non-ischemic group.
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Figure 6.
Ki values measured with AIB in the non-ischemic (n=4), I/R-4-treated (n=5), I/R-24-treated
(n=4), and I/R-48-treated (n=5) fetuses plotted against claudin-5 protein expression in the
cerebral cortex. Stepwise multiple regression analysis using the Dummy coding variables, r
= −0.54, n=18, P<0.05.
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Table 1
The days of gestation, body, and brain weights of the ovine fetuses.
Sham Control
(N = 5)
I/R-4
(N = 5)
I/R-24
(N = 5)
I/R-48
(N = 5)
Gestation (days) 127 ± 2 126 ± 1 126 ± 2 127 ± 1
Brain weight (g) 42.7 ± 9.6 39.8 ± 2.5 35.7 ± 10.4 41.6 ± 5.2
Body weight (kg) 3.24 ± 0.2 2.79 ± 0.7 2.94 ± 0.4 3.05 ± 0.4
Values are means ± SD, n= number of animals. The gestational ages, brain weights and body weights did not differ among the study groups.
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Table 3
Brain blood volume measured with Tc-99M labeled ovine red blood cells
Brain Regions
(µL/g brain)
Sham Control
(N = 5)
I/R-4
(N = 5)
I/R-24
(N = 5)
I/R-48
(N = 5)
Cerebral Cortex 23.1 ± 5.8 19.0 ± 6.1 37.4 ± 12.3 *+ 33 ± 14.5 +
White Matter 12.4 ± 4.9 21.5 ± 15.1 26.5 ± 3.4 * 15.9 ± 5.1 ++
Caudate Nucleus 15.6 ± 1.1 8.6 ± 5.5 21.6 ± 7.5 15.5 ± 14.1
Hippocampus 17.1 ± 3.1 11.8 ± 5.7 33.4 ± 20.0 21.0 ± 11.4
Cerebellum 35.6 ± 13.9 20.8 ± 3.8 51.1 ± 11.7 + 40.3 ± 14.6 +
Thalamus 16.5 ± 5.8 13.8 ± 4.9 21.2 ± 10.9 22.7 ± 14.4
Superior Colliculus 17.1 ± 3.2 14.8 ± 6.5 24.4 ± 7.1 22.9 ± 14.3
Inferior Colliculus 25.9 ± 12.5 25.0 ± 11.3 38.3 ± 22.3 34.3 ± 18.9
Pons 32.9 ± 20.8 18.3 ± 7.8 40.8 ± 29.0 26.1 ± 15.0
Medulla 25.3 ± 11.7 17.0 ± 4.1 55.8 ± 39.3 29.3 ± 15.9
Spinal cord 22.5 ± 7.9 24.0 ± 7.2 33.4 ± 18.3 21.1 ± 7.8
Values are means ± SD, n= number of animals.
*P<0.05 vs. sham operated control group,
+P<0.05 vs. I/R-4 group,
++P<0.05 vs. I/R-24 group.
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